Gil Solomon & Co. advised FertilAI in its $5m financing round.

FertilAI has secured a Preferred Seed Round providing for investment from Longevity Venture Partners, Redseed Ventures, F Capital, and additional investors of up to US$ 5,000,000.

FertilAI is revolutionizing the fertility treatment field with ground breaking algorithms and artificial intelligence solutions. FertilAI's innovative platform, Fertilane, goes beyond typical software solutions—it's a clinically validated, AI-driven tool supported by extensive research and real-world success. Fertilane's core is a powerful set of algorithms, meticulously developed through the analysis of over 100,000 patient records and tens of millions of data sets, has undergone rigorous validation. Its success is recognized in leading scientific journals and at major fertility conferences worldwide.

‍